Search results
What Makes Kirin (KNBWY) a New Strong Buy Stock
Zacks via Yahoo Finance· 1 week agoKirin (KNBWY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the...
Has Kirin (KNBWY) Outpaced Other Consumer Staples Stocks This Year?
Zacks via Yahoo Finance· 2 years agoThe Consumer Staples group has plenty of great stocks, but investors should always be looking for...
Kirin Holdings Co Ltd's Dividend Analysis
GuruFocus.com via Yahoo Finance· 6 months agoKirin Holdings Co Ltd (KNBWF) recently announced a dividend of $34.5 per share, payable on a date yet to be confirmed, with the ex-dividend date set for...
The Zacks Analyst Blog Highlights Compania Cervecerias Unidas, Kirin Holdings and Anheuser-Busch...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – February 15, 2023 – Zacks.com announces the list of stocks...
Best Momentum Stock to Buy for June 13th
Zacks via Yahoo Finance· 6 days agoHere are three stocks with buy rank and strong momentum characteristics for investors to consider today, June13th: Kirin KNBWY: This company which is...
Is Kirin (KNBWY) Stock Undervalued Right Now?
Zacks via Yahoo Finance· 1 year agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks....
New Strong Buy Stocks for February 17th
Zacks via Yahoo Finance· 1 year agoHere are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Kirin Holdings Company, Limited KNBWY: This food and beverages, pharmaceuticals,...
KNBWY or SAM: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Finance· 2 days agoInvestors interested in Beverages - Alcohol stocks are likely familiar with Kirin Holdings Co....
KNBWY vs. DEO: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 2 years agoInvestors with an interest in Beverages - Alcohol stocks have likely encountered both Kirin Holdings...
Why Orchard Therapeutics Stock Is Soaring Today
Motley Fool· 8 months agoShares of the commercial-stage gene therapy company Orchard Therapeutics (NASDAQ: ORTX) were up by a noteworthy 98% on sky-high volume as of 10:13 a.m....